Get started
Author

Ataru Igarashi

Japan's health system toward 2040: structural challenges and a renewed social contract
2026 · Lisa Yamasaki, Haruka Sakamoto, et al. · The Lancet Regional Health - Western Pacific · 3
Trends in Adverse Event Reports of Dipeptidyl Peptidase-4 Inhibitor-Associated Pemphigoid in Japan
2026 · Akina Takami, Gen Terashima, et al. · Drugs - Real World Outcomes · 3
PDF
Estimating respiratory syncytial virus health utility values for older adults and their caregivers in the Japanese population: a time trade-off study
2026 · Regina Rendas-Baum, Jakob Bjorner, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2
PDF
Effectiveness of JN.1-adapted COVID-19 vaccine against medically attended SARS-CoV-2 infection and COVID-19 hospitalization in adults in Japan, from October 2024 to April 2025: VERSUS
2026 · Haruka Maeda, Nobuo Saito, et al. · Vaccine · 2
Toward Responsible Research Culture Indicators: A Six-Dimensional Framework for Cultivating Researcher Wellbeing and Human Flourishing
2026 · Tomoko Sakai, Karel Svadlenka, et al. · Zenodo (CERN European Organization for Nuclear Research) · 1
What research culture is for: a six-dimensional framework co-created to cultivate researcher wellbeing
2026 · Tomoko Sakai, Karel Svadlenka, et al. · MetArXiv (OSF Preprints) · 1
Japan's global health engagement in the Western Pacific: diagnosing structural inertia and a framework for human security diplomacy
2026 · Haruka Sakamoto, Lisa Yamasaki, et al. · The Lancet Regional Health - Western Pacific · 1
Economic consequences when enteral tube feeding intolerance causes unplanned discontinuation in hospitalized older patients with gastroesophageal reflux disease
2025 · Yukikazu Kamada, Kanako Kawano, et al. · Clinical Nutrition ESPEN · 1
Research culture framework: development record and supplementary materials
2026 · Tomoko Sakai, Karel Svadlenka, et al.
Interim analysis of effectiveness of JN.1-adapted conventional and self-amplifying mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infection in adults aged ≥60 years, Japan, October 2024–April 2025
2026 · Haruka Maeda, Ataru Igarashi, et al. · Vaccine
PDF
Disease burden and quality of life in caregivers of infants with RSV lower respiratory tract infections in Japan
2026 · Ataru Igarashi, Koo Nagasawa, et al. · Japanese Journal of Infectious Diseases
PDF
Estimating respiratory syncytial virus health utility values for older adults and their caregivers in the Japanese population: a time trade-off study
2026 · Regina Rendas-Baum, Jakob Bjorner, et al. · Figshare
Return on investment of national specific health guidance in Japan: an observational study using “Wellness-Star⋆” health insurance claims database
2026 · Ueda, Takuma, Kakinuma, Akihiro, et al. · Figshare
Return on investment of national specific health guidance in Japan: an observational study using “Wellness-Star⋆” health insurance claims database
2026 · Takuma Ueda, Akihiro Kakinuma, et al. · Journal of Medical Economics
Designing an Indicator‑Driven, Value‑Based Architecture for Pneumonia Prevention in Japan: A Formative Policy Viewpoint on Adult Vaccination and Oral Care
2026 · Kazumi Kubota, Ataru Igarashi, et al. · JMIR Formative Research
PDF
Updated Conversion Table for the Multiple Criteria Qualitative Value-Based Pricing Framework “MARIE”
2026 · Akina Takami, Ataru Igarashi · Journal of Market Access & Health Policy
PDF
Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test among node-negative early breast cancer patients in Japan
2026 · Kei Koizumi, Ataru Igarashi, et al. · Breast Cancer
PDF
Incidence of COVID-19-Associated Hospitalization by Vaccination Status in Children and Adolescents During Omicron-Dominant Period in Japan: The VENUS Study
2026 · Haruka Maeda, Michiko Toizumi, et al. · Children
PDF
Endoscopic Examination and Long-Term Use of Proton Pump Inhibitors for Gastroesophageal Reflux Disease Treatment in Japan
2026 · Akina Takami, Gen Terashima, et al. · Drug Healthcare and Patient Safety
PDF
Impact of Blood‐Based Biomarkers on Access to Alzheimer's Disease Treatments: A Simulation Study in Japan
2025 · Ataru Igarashi, Noriyuki Kimura, et al. · Alzheimer s & Dementia
PDF
Author response for "Incidence of RSV- and Influenza-Associated Hospitalizations With Community-Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan in 2022-2024: APSG-J2 Study"
2025 · Maeda, Haruka, Masuda, Shingo, et al. · Publons reviews and discussion
Einblick: Health Technology Assessment in Japan – ein Stimmungsbild
2025 · Ataru Igarashi · Springer eBooks
PDF
Works count: 26
Citation count: 14
H-index: 2
I10-index:
Year
Topic
Type